Vanguard Group
RCPI

Vanguard Group’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Vanguard Group’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-188,908
Closed -$155K – 4277
2015
Q3 		$155K Buy
188,908
+11,704
+7% +$13K ﹤0.01% 4055
2015
Q2 		$269K Buy
177,204
+10,427
+6% +$24.8K ﹤0.01% 3994
2015
Q1 		$426K Buy
166,777
+1,848
+1% +$7.27K ﹤0.01% 3871
2014
Q4 		$750K Sell
164,929
-1,653
-1% -$8.69K ﹤0.01% 3615
2014
Q3 		$1.17M Buy
166,582
+2,741
+2% +$27.1K ﹤0.01% 3459
2014
Q2 		$2.42M Buy
+163,841
New +$2.84M ﹤0.01% 3181

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
WP
WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return
IWMPD
Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Vanguard Group's RCPI Position: Q4 2015 in Review

Vanguard Group sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 188,908 shares — an estimated $155K sold.

Vanguard Group first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $2.42M in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • Vanguard Group reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Vanguard Group sold 188,908 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $155K.
  • Vanguard Group first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
  • Vanguard Group's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $2.42M in Q2 2014.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Vanguard Group's 13F filing for Q4 2015, filed 8 Feb 2016.